Announce Date | 07/30/2025 |
EPS Normalized Actual | $0.49 (Beat by $0.04) |
EPS GAAP Actual | $0.49 (Beat by $0.04) |
Revenue Actual | $0.160357B |
Revenue Surprise | Beat by $160.357M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.7 |
EPS GAAP Estimate | $0.7 |
Revenue Estimate | $0.1686B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2027 | 2.43 | 12 | 2.42231 | 2.43769 | 1 |
Jun 2026 | 3.38 | 8.63 | 3.35574 | 3.49051 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.48 | 0.48 | 0.160357B | -5.16% | 160.36M |
FQ1 2025 (Mar 2025) | 0.38 | -0.36 | 0.142695B | -2.61% | -33.11M |
FQ4 2024 (Dec 2024) | 0.59 | 0 | 0.15726B | -6.37% | 0.36M |
FQ3 2024 (Sep 2024) | 0.58 | -0.96141 | 0.154337B | -6.19% | -173.45M |
FQ2 2024 (Jun 2024) | 0 | 0 | 0.168632B | -11.11% | 168.63M |
FQ1 2024 (Mar 2024) | 0.51 | 0.51 | 0.146421B | -27.25% | 146.42M |
FQ4 2023 (Dec 2023) | 0.68 | 0.68 | 0.167276B | -21.45% | 167.28M |
FQ3 2023 (Sep 2023) | 0.59 | 0.59 | 0.163892B | -30.9% | 163.89M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.7
Consensus Revenue Estimates
0.1686B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.48 | -- | 0.4777 | 0.4823 | 1 |
FQ4 2026 (Dec 2026) | 0.6 | -- | 0.59712 | 0.60288 | 1 |
FQ3 2026 (Jul 2026) | 0.79535 | -- | 0.79535 | 0.79535 | 0 |
FQ1 2026 (Mar 2026) | 0.42 | 9.52 | 0.41656 | 0.42344 | 0 |
FQ4 2025 (Oct 2025) | 0.65661 | 10.14 | 0.65661 | 0.65661 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
FQ4 2026 (Dec 2026) | 0.17B | -- | 0.17B | 0.17B | 1 |
FQ3 2026 (Jul 2026) | 0.16B | -- | 0.16B | 0.16B | 0 |
FQ1 2026 (Mar 2026) | 0.15B | 4.74 | 0.15B | 0.15B | 0 |
FQ4 2025 (Oct 2025) | 0.15B | -3.01 | 0.15B | 0.15B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.48 | 0.48 | 100% | |
FQ1 2025 (Mar 2025) | 0.74 | 0.38 | -0.36 | -94.74% |
FQ4 2024 (Dec 2024) | 0.59 | 0.59 | 0 | 0% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.58 | -0.96141 | -165.76% |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0.51 | 0.51 | 100% | |
FQ4 2023 (Dec 2023) | 0.68 | 0.68 | 100% | |
FQ3 2023 (Sep 2023) | 0.59 | 0.59 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.16B | $160.36M | 100% |
FQ1 2025 (Mar 2025) | $0.18B | $0.14B | $-33.11M | -23.2% |
FQ4 2024 (Dec 2024) | $0.16B | $0.16B | $0.36M | 0.23% |
FQ3 2024 (Sep 2024) | $0.33B | $0.15B | $-173.45M | -112.38% |
FQ2 2024 (Jun 2024) | $0B | $0.17B | $168.63M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.15B | $146.42M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.17B | $167.28M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.16B | $163.89M | 100% |